Publikationen, an denen er mitarbeitet Alfonso Muriel García (19)

2024

  1. Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial

    Chest, Vol. 165, Núm. 3, pp. 673-681

  2. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation

  3. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

    eClinicalMedicine, Vol. 73

2023

  1. Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study

    Thrombosis Research, Vol. 228, pp. 1-9

2022

  1. Statin use and 30-day mortality in patients with acute symptomatic pulmonary embolism

    Journal of Thrombosis and Haemostasis, Vol. 20, Núm. 8, pp. 1839-1851

2021

  1. Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism

    European Respiratory Journal, Vol. 58, Núm. 1

  2. Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial

    JAMA - Journal of the American Medical Association, Vol. 326, Núm. 13, pp. 1277-1285

2020

  1. Derivation and validation of a clinical prediction rule for thrombolysis-associated major bleeding in patients with acute pulmonary embolism: The BACS score

    European Respiratory Journal, Vol. 56, Núm. 6

  2. Implications of Abnormal Troponin Levels With Normal Right Ventricular Function in Normotensive Patients With Acute Pulmonary Embolism

    Clinical and Applied Thrombosis/Hemostasis, Vol. 26

2019

  1. Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU

    Alimentary Pharmacology and Therapeutics, Vol. 49, Núm. 4, pp. 419-428

  2. Hospital volume and outcomes for acute pulmonary embolism: Multinational population based cohort study

    The BMJ, Vol. 366

  3. The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease

    Clinical Cardiology, Vol. 42, Núm. 3, pp. 346-351

2018

  1. Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy

    European Respiratory Journal

2017

  1. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

    American Journal of Medicine, Vol. 130, Núm. 5, pp. 588-595

2016

  1. DVT Management and Outcome Trends, 2001 to 2014

    Chest, Vol. 150, Núm. 2, pp. 374-383

  2. Effectiveness of prognosticating pulmonary embolism using the ESC algorithm and the Bova score

    Thrombosis and Haemostasis, Vol. 115, Núm. 4, pp. 827-834

2012

  1. Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism

    Journal of Thrombosis and Haemostasis, Vol. 10, Núm. 5, pp. 751-759

2010

  1. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism

    Archives of Internal Medicine, Vol. 170, Núm. 15, pp. 1383-1389

2009

  1. Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism: Systematic review and metaanalysis

    Chest, Vol. 136, Núm. 4, pp. 974-982